We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

32 hedge funds and large institutions have $6.36M invested in SQZ Biotechnologies Company in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 35 → 32 (-3)

32% less capital invested

Capital invested by funds: $9.35M → $6.36M (-$2.99M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
7
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$218K
2
Millennium Management
Millennium Management
New York
+$77.7K
3
TSS
Two Sigma Securities
New York
+$26.6K
4
SG Americas Securities
SG Americas Securities
New York
+$20.2K
5
VF
Virtu Financial
New York
+$12.6K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$985K
2
Stifel Financial
Stifel Financial
Missouri
-$119K
3
E
Ergoteles
New York
-$47.5K
4
RC
RBF Capital
California
-$39.2K
5
Jane Street
Jane Street
New York
-$31.8K

SQZ Hedge Fund Activity: Q1 2023 in Review

32 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q1 2023, worth a combined $6.36M — down 32% from $9.35M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SQZ and 4 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Morgan Stanley, adding an estimated $218K. The largest seller was 683 Capital Management, exiting entirely with an estimated $985K sold.

  • 32 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q1 2023, down from 35 in Q4 2022.
  • Funds reported $6.36M of SQZ Biotechnologies Company stock for Q1 2023, down 32% quarter-over-quarter.
  • 4 funds opened new SQZ Biotechnologies Company positions in Q1 2023 and 7 closed out, a net change of -3 holders.
  • The largest SQZ Biotechnologies Company buyer in Q1 2023 was Morgan Stanley, an estimated $218K added.
  • The largest SQZ Biotechnologies Company seller in Q1 2023 was 683 Capital Management, an estimated $985K sold.

Based on aggregated 13F filings for Q1 2023.